OpenAlex 4.568 eser 141 yazar konusu
Çalışmalar
4.568 eser
-
YÖKSİS
SJR Q1
JCR Q1
OpenAlex üst %1
OpenAlex 100.0%
BACKGROUND: Previous global analyses, with known underdiagnosis and single cause per death attribution systems, provide only a small insight into the suspected high population health effect of sickle cell disease. Completed as part of the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2021, this stu…
-
YÖKSİS
SJR Q1
JCR Q1
OpenAlex üst %1
OpenAlex 99.5%
Deferasirox (ICL670) is a once-daily oral iron chelator developed for the treatment of chronic iron overload from blood transfusions. A comparative phase 3 trial was conducted to demonstrate the efficacy of deferasirox in regularly transfused patients with beta-thalassemia aged 2 years or older. Patients were randomiz…
-
YÖKSİS
SJR Q1
JCR Q1
OpenAlex üst %1
OpenAlex 99.9%
BACKGROUND: Deoxygenated sickle hemoglobin (HbS) polymerization drives the pathophysiology of sickle cell disease. Therefore, direct inhibition of HbS polymerization has potential to favorably modify disease outcomes. Voxelotor is an HbS polymerization inhibitor. METHODS: In a multicenter, phase 3, double-blind, rando…
-
OpenAlex üst %1
OpenAlex 100.0%
BACKGROUND: Anaemia is a major health problem worldwide. Global estimates of anaemia burden are crucial for developing appropriate interventions to meet current international targets for disease mitigation. We describe the prevalence, years lived with disability, and trends of anaemia and its underlying causes in 204…
-
YÖKSİS
SJR Q1
JCR Q1
OpenAlex üst %1
OpenAlex 100.0%
BACKGROUND: Anaemia is a major health problem worldwide. Global estimates of anaemia burden are crucial for developing appropriate interventions to meet current international targets for disease mitigation. We describe the prevalence, years lived with disability, and trends of anaemia and its underlying causes in 204…
-
YÖKSİS
SJR Q1
JCR Q1
OpenAlex üst %1
OpenAlex 100.0%
BACKGROUND: Anaemia is a major health problem worldwide. Global estimates of anaemia burden are crucial for developing appropriate interventions to meet current international targets for disease mitigation. We describe the prevalence, years lived with disability, and trends of anaemia and its underlying causes in 204…
-
OpenAlex üst %1
OpenAlex 99.9%
BACKGROUND: Patients with anemia and lower-risk myelodysplastic syndromes in whom erythropoiesis-stimulating agent therapy is not effective generally become dependent on red-cell transfusions. Luspatercept, a recombinant fusion protein that binds transforming growth factor β superfamily ligands to reduce SMAD2 and SMA…
-
Özet henüz yok.
-
YÖKSİS
SJR Q1
JCR Q1
OpenAlex üst %10
OpenAlex 99.0%
Iron is an essential trace mineral that plays a number of important physiological roles in humans, including oxygen transport, energy metabolism, and neurotransmitter synthesis. Iron absorption by the proximal small bowel is a critical checkpoint in the maintenance of whole-body iron levels since, unlike most other es…
-
YÖKSİS
SJR Q1
JCR Q1
OpenAlex üst %10
OpenAlex 98.9%
Plasma xanthine oxidase (XO) activity was defined as a source of enhanced vascular superoxide (O \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \setlength{\oddsidemargin}{-69pt} \begin{document} \begin{equatio…
-
YÖKSİS
SJR Q1
JCR Q1
OpenAlex üst %1
OpenAlex 99.6%
BACKGROUND: The optimal iron therapy regimen in patients with non-dialysis-dependent chronic kidney disease (CKD) is unknown. METHODS: Ferinject® assessment in patients with Iron deficiency anaemia and Non-Dialysis-dependent Chronic Kidney Disease (FIND-CKD) was a 56-week, open-label, multicentre, prospective and rand…
-
YÖKSİS
SJR Q1
JCR Q1
OpenAlex üst %1
OpenAlex 99.7%
BACKGROUND: Patients with transfusion-dependent β-thalassemia need regular red-cell transfusions. Luspatercept, a recombinant fusion protein that binds to select transforming growth factor β superfamily ligands, may enhance erythroid maturation and reduce the transfusion burden (the total number of red-cell units tran…
Akademisyenler
141 akademisyen
- MEHMET NEJAT AKAR 73 yazar konusu
- SELMA ÜNAL 59 yazar konusu
- BİROL GÜVENÇ 36 yazar konusu
- CAN ACIPAYAM 27 yazar konusu
- DENİZ ASLAN 21 yazar konusu
- AYLİN YÜCEL 20 yazar konusu
- MURAT SÖKER 20 yazar konusu
- NİHAL KARADAŞ 16 yazar konusu
- ONUR ÖZTÜRK 15 yazar konusu
- AYLİN KÖSELER 14 yazar konusu
- ECE MEKİK 14 yazar konusu
- EMEL GÜRKAN 14 yazar konusu